Cargando…
Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β(+) T Cells and Differentiated γδ T Cells Alongside a Regulatory Response Mediated by FOXP3(+) T Cells and Immunoregulatory Molecules
In recent years, immunotherapy has shown considerable promise in the management of several malignancies. However, the majority of preclinical studies have been conducted in rodents, the results of which often translate poorly to patients given the substantial differences between murine and human imm...
Autores principales: | Overgaard, Nana H., Principe, Daniel R., Schachtschneider, Kyle M., Jakobsen, Jeanne Toft, Rund, Laurie A., Grippo, Paul J., Schook, Lawrence B., Jungersen, Gregers |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999797/ https://www.ncbi.nlm.nih.gov/pubmed/29930558 http://dx.doi.org/10.3389/fimmu.2018.01301 |
Ejemplares similares
-
The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform
por: Schachtschneider, Kyle M., et al.
Publicado: (2017) -
Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas
por: Schachtschneider, Kyle M., et al.
Publicado: (2017) -
The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery
por: Segatto, Natalia V., et al.
Publicado: (2017) -
The Oncopig as an Emerging Model to Investigate Copper Regulation in Cancer
por: Carlson, Alyssa L., et al.
Publicado: (2022) -
Editorial: “Humanized” Large Animal Cancer Models: Accelerating Time and Effectiveness of Clinical Trials
por: Schachtschneider, Kyle M., et al.
Publicado: (2019)